These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38494285)

  • 41. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies.
    Sanders DB
    Ann Neurol; 1995 May; 37 Suppl 1():S63-73. PubMed ID: 8968218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
    Flink MT; Atchison WD
    J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.
    Gilhus NE
    Autoimmune Dis; 2011; 2011():973808. PubMed ID: 21969911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [LEMS: Clinical Significance of Pathogenic Autoantibodies].
    Motomura M; Irioka T
    Brain Nerve; 2023 Jul; 75(7):837-845. PubMed ID: 37431074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer detection after a 9-year course of Lambert-Eaton myasthenic syndrome complicated by anti-Hu associated limbic encephalitis.
    Falso S; Spagni G; Iorio R; Evoli A
    Neuromuscul Disord; 2023 Sep; 33(9):90-92. PubMed ID: 37507235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lambert-Eaton myasthenia syndrome--review with case report].
    Engler F
    Fortschr Neurol Psychiatr; 1990 Dec; 58(12):447-54. PubMed ID: 1964928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Voltage gated calcium channel antibody-related neurological diseases.
    Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
    World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amifampridine to treat Lambert-Eaton myasthenic syndrome.
    Oh SJ
    Drugs Today (Barc); 2020 Oct; 56(10):623-641. PubMed ID: 33185628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
    Vincent A; Lang B; Newsom-Davis J
    Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lambert-Eaton myaesthenic syndrome: a possible association with Hodgkin's lymphoma.
    Tyagi A; Connolly S; Hutchinson M
    Ir Med J; 2001 Jan; 94(1):18-9. PubMed ID: 11322220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lambert-Eaton Myasthenic syndrome: early diagnosis is key.
    Ivanovski T; Miralles F
    Degener Neurol Neuromuscul Dis; 2019; 9():27-37. PubMed ID: 31191084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myasthenia gravis Lambert-Eaton overlap syndrome.
    Oh SJ
    Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.